Skip to main content
Log in

The UK NICE has released draft guidelines for the use of amantadine, oseltamivir and zanamivir for influenza prophylaxis.

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. National Institute for Health and Clinical Excellence.Influenza (prophylaxis) - amantidine, oseltamivir and zanamivir: appraisal consultation document. Internet Document: [19 pages], 4 Jun 2008. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The UK NICE has released draft guidelines for the use of amantadine, oseltamivir and zanamivir for influenza prophylaxis.. Pharmacoecon. Outcomes News 555, 7 (2008). https://doi.org/10.2165/00151234-200805550-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805550-00011

Keywords

Navigation